29 /100
MEDIUM RISK
Score updated May 30, 2026

PHAT — Phathom Pharmaceuticals, Inc. Dilution Risk Tracker

Track PHAT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PHAT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PHAT.
🔔 Track PHAT — Get forecast alerts →

💹 Market Data

Market Cap$764.86M
Shares Outstanding79.76M
Float60.39M
Cash$180.90M
Debt$547.22M
Short InterestN/A

🏛 Institutional Holdings

88.4% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track PHAT for full holder detail →

📉 Short Interest

Short Interest10.29M
Days to Cover8.7
% of Float17.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2021
xbrl XBRL CONVERTIBLE Dec 31, 2019
4 INSIDER TRANSACTION Mar 11, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Feb 12, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track PHAT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PHAT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for PHAT
📊 PHAT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PHAT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.